Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Evaluation of radionuclidic profiles of molybdenum-99 from accelerator transmutation of natural and Mo-100 enriched molybdenum

Eric Pellerin, Kelly Ogbomo, John Barnard, Chris Saunders and Kennedy Mangera
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1485;
Eric Pellerin
1Radiopharmaceuticals Research Group, Health Sciences Centre, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Ogbomo
1Radiopharmaceuticals Research Group, Health Sciences Centre, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Barnard
2Acsion Industries, Pinawa, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Saunders
2Acsion Industries, Pinawa, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kennedy Mangera
1Radiopharmaceuticals Research Group, Health Sciences Centre, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1485

Objectives Evaluate the profiles of two sources of accelerator produced molybdenum-99 by γ-ray spectroscopy with the use of a High Purity Germanium detector (HPGe).

Methods Enriched Mo (>99% Mo-100) was irradiated in a stack of 10 5-mm sintered disks of 0.5g each, with a total yield of 5.1GBq. Natural Mo metal (10% Mo-100) was irradiated in a stack of 20 12.5-mm disks of about 5g each, with a total yield of 2.84GBq. One disk from each source was used for γ-ray spectroscopy, the others were dissolved and used with our solvent extraction generator technology to produce Tc99m, with samples taken for this study. γ-ray spectroscopy was performed regularly at 15cm, 45cm and 75cm from the detector for a period up to 40 days. HPGe spectra for the dissolution and extraction samples were similarly obtained.

Results The high initial activity of the enriched Mo saturates the HPGe detector at 15cm. Useable spectra was possible only after 8-day decay for 15cm or for the initial sample at 75cm. The spectra show distinct peaks of attributable only to Mo99 (Fig 1A) (peaks at 140, 180, 366, 739, 777, 822 and 960 keV). However, at day 40 (Fig 1B) significant decay and minimization of Mo99 allows visualization of impurities, with peaks of Zr95, Nb95 and Sc46. For natural molybdenum, impurity peaks of Nb96 show up initially but decay rapidly due to shorter half-life (23.35h). At 15 days, Nb96 peaks disappear and peaks for Nb91m, Nb92m, Nb95m and Nb95 are clearly prominent (t1/2= 60.86d, 10.15d, 86.6h, 35.15d, respectively).

Conclusions HPGe γ-ray spectroscopy demonstrates the advantage of using Mo-100 enriched raw material to obtain Mo99 product of high radionuclic purity. Quantitation of impurities from the two sources for compliance to compendial limits, and an efficient extraction process that excludes radionuclidic impurities in the final Tc-99m product are therefore important parameters.

Research Support Non-Reactor Isotope Support Program, Natural Resources Canada and the Winnipeg Health Sciences Centre Foundatio

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of radionuclidic profiles of molybdenum-99 from accelerator transmutation of natural and Mo-100 enriched molybdenum
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of radionuclidic profiles of molybdenum-99 from accelerator transmutation of natural and Mo-100 enriched molybdenum
Eric Pellerin, Kelly Ogbomo, John Barnard, Chris Saunders, Kennedy Mangera
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1485;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of radionuclidic profiles of molybdenum-99 from accelerator transmutation of natural and Mo-100 enriched molybdenum
Eric Pellerin, Kelly Ogbomo, John Barnard, Chris Saunders, Kennedy Mangera
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1485;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • A radioactive method for assessing microbial safety of an infusion set for contrast-enhanced imaging
  • Cathepsin K inhibitors for in vivo osteoclast imaging by PET
  • Nonradioactive analytical methods for quantifying the modification ratio of antibody chelator conjugates (ACCs) with deferroxamine and DOTA
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Automation & Technology Development Posters

  • Microfluidic 2-step radiosynthesis of [18F]FEMPT, a high affinity PET radiotracer for 5-HT1AR
  • Efficient GMP production of 68Ga-peptides on a commercial synthesizer using a 68Ge/68Ga generator with direct labelling
  • Automated production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for the Glucagonlike Peptide 1 Receptor imaging
Show more Special MTA: Automation & Technology Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire